Phase determination using chromosomal microarray and fluorescence in situ hybridization in a patient with early onset Parkinson disease and two deletions in PRKN
Open Access
- 25 March 2018
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 6 (3) , 457-462
Abstract
Background: Mutations in the parkin gene (PRKN) are the most commonly identified genetic factors in early onset Parkinson disease (EOPD), with biallelic mutations, resulting in a clinical phenotype. However, normal variation is also common in PRKN, particularly in the form of copy number variation (CNV), challenging interpretation of genetic testing results. Here we report a case of a 29‐year‐old male with EOPD and two deletions in PRKN detected by chromosomal microarray (CMA).Methods: The proband was clinically examined by a neurologist for postural instability with frequent falls, bradykinesia, gait freezing with festination, and hypophonia. Chromosomal microarray analysis (CMA) was performed on the proband and his parents using the Affymetrix CytoScan HD microarray. Subsequent fluorescence in situ hybridization (FISH) was performed on the proband and both parents.Results: Chromosomal microarray detected the presence of two deletions of PRKN in the proband. Parental CMA analysis was performed to determine the clinical significance of this finding, as well as to demonstrate phase of these deletions. Parental CMA revealed that one deletion was paternally inherited and one deletion was de novo. A custom FISH approach was then successfully used to phase the deletions.Conclusion: Chromosomal microarray and fluorescence in situ hybridization analysis of this trio identified two deletions in PRKN occurring in trans, providing a genetic etiology for the clinical diagnosis of EOPD. The determination of inheritance and phase of the deletions was critical to the proper interpretation of these results. These findings highlight the utility of CMA in the detection of clinically relevant CNVs in cases of EOPD, and also serve to emphasize the importance of follow‐up FISH and parental testing.Keywords
This publication has 15 references indexed in Scilit:
- Comparing clinical features of young onset, middle onset and late onset Parkinson's diseaseParkinsonism & Related Disorders, 2014
- Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation updateHuman Mutation, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010
- Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutationsNeurology, 2009
- Case-Control Study of the Parkin Gene in Early-Onset Parkinson DiseaseArchives of Neurology, 2006
- Distribution, type, and origin of Parkin mutations: Review and case studiesMovement Disorders, 2004
- Parkin mutations are frequent in patients with isolated early‐onset parkinsonismBrain, 2003
- Association between Early-Onset Parkinson's Disease and Mutations in theParkinGeneNew England Journal of Medicine, 2000
- A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in EuropeHuman Molecular Genetics, 1999
- Mutations in the parkin gene cause autosomal recessive juvenile parkinsonismNature, 1998